In the evolving landscape of oncology, precision medicine has emerged as a beacon of
hope, tailoring treatments to individual patients based on their unique genetic profiles. This …

The recent revolution in science and technology applied to medical research has left in its
wake a trial of biomedical data and human samples; however, its opportunities remain …

The France Genomic Medicine 2025 Plan (PFMG2025) is a national policy organizing and
financing the access to whole genome sequencing in care setting. All patients in the country …

In the era of big data and artificial intelligence, biomedical research and healthcare have
been presented with unprecedented opportunities for improving the understanding of cancer …

The intersection of data governance and machine learning in clinical trials presents a
transformative synergy, enhancing data integrity, security, and decision-making. This paper …

The intersection of data governance and machine learning in clinical trials presents a
transformative synergy, enhancing data integrity, security, and decision-making. This paper …

Precision medicine is at the forefront of innovation in cancer care. With the development of
technologies to rapidly sequence DNA from tumors, cell-free DNA, proteins, and even …

In the information age, we expect data systems to make us more effective and efficient—not
to make our lives more difficult! In this article, we discuss how we are using data systems …

The increasing application of AI-led systems for oncology drug development and patient
care holds the potential to usher pronounced impacts for patients' well-being. Beyond …

There are bioethical, institutional, economic, legal, and cultural obstacles to creating the
robust-precompetitive-data resource that will be required to advance the vision of “precision …